Quick Search:

uzh logo
Browse by:
bullet
bullet
bullet
bullet

Zurich Open Repository and Archive

Huber, M; Olson, W C; Trkola, A (2008). Antibodies for HIV treatment and prevention: window of opportunity? Current Topics in Microbiology and Immunology, 317:39-66.

Full text not available from this repository.

View at publisher

Abstract

Monoclonal antibodies are routinely used as therapeutics in a number of disease settings and have thus also been explored as potential treatment for human immunodeficiency virus (HIV)-1 infection. Antibodies targeting viral antigens, and those directed to the cellular receptors, have been considered for use in prevention and therapy. For virus-targeted antibodies, attention has focused primarily on their neutralizing activity, but such antibodies also have the potential to exert antiviral effects via effector functions, such as antibody-dependent cellular cytotoxicity (ADCC), opsonization, or complement activation. Anti-cell antibodies act through occlusion or down-modulation of the viral receptors with notable impact in vivo, as recent trials have shown. This review summarizes the diverse specificities and modes of action of therapeutic antibodies against HIV-1 infection. Successes, challenges, and future opportunities of harnessing antibodies for therapy of HIV-1 infection are discussed.

Citations

16 citations in Web of Science®
16 citations in Scopus®
Google Scholar™

Altmetrics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Infectious Diseases
DDC:610 Medicine & health
Language:English
Date:2008
Deposited On:15 Dec 2008 15:36
Last Modified:23 Nov 2012 16:34
Publisher:Springer
ISSN:0070-217X
Additional Information:The original publication is available at www.springerlink.com
Publisher DOI:10.1007/978-3-540-72146-8_2
PubMed ID:17990789

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page